{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:01:46Z","timestamp":1790038906162,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1078930"],"award-info":[{"award-number":["1078930"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["0001-001094"],"award-info":[{"award-number":["0001-001094"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cmi.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:38:39Z","timestamp":1776015519000},"page":"1684-1692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between \u03b2-lactam exposure and clearance of bacteraemia and acute kidney injury in patients with methicillin-resistant Staphylococcus aureus bloodstream infections\u2014a post hoc analysis of the CAMERA2 trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Neta","family":"Petersiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Legg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean W.X.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ovadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giulieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.04.006_bib1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: A systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.04.006_bib2","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jama.2025.4288","article-title":"Management of Staphylococcus aureus bacteremia: A review","volume":"334","author":"Tong","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.04.006_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: A pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal beta-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: A randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciaa1081","article-title":"Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant Staphylococcus aureus bacteremia and endocarditis: A randomized clinical trial","volume":"72","author":"Pujol","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2026.04.006_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40261-022-01204-z","article-title":"Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: A post hoc analysis of the CAMERA2 trial","volume":"43","author":"Legg","year":"2023","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.cmi.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13063-016-1295-3","article-title":"CAMERA2\u2014Combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: Study protocol for a randomised controlled trial","volume":"17","author":"Tong","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2026.04.006_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa538","article-title":"CAMERA2 Study Group. Vancomycin exposure and acute kidney injury outcome: A snapshot from the CAMERA2 study","volume":"7","author":"Liu","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib11","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.04.006_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad337","article-title":"Longer-term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) trial: A post hoc analysis","volume":"10","author":"Legg","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): Executive summary","volume":"107","author":"Torres","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2026.04.006_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/nep.14246","article-title":"Avoiding misclassification of acute kidney injury: Timing is everything","volume":"29","author":"Legg","year":"2024","journal-title":"Nephrology (Carlton)."},{"key":"10.1016\/j.cmi.2026.04.006_bib15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cmi.2024.09.011","article-title":"Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: A causal inference approach using data from the Eurobact2 study","volume":"30","author":"Loiodice","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.01204-13","article-title":"\u03b2-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.04.006_bib17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/phar.2034","article-title":"Early administration of adjuvant \u03b2-lactam therapy in combination with vancomycin among patients with methicillin-resistant Staphylococcus aureus bloodstream infection: A retrospective, multicenter analysis","volume":"37","author":"Casapao","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2026.04.006_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02211-18","article-title":"Adjuvant \u03b2-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus bacteremia: Does \u03b2-lactam class matter?","volume":"63","author":"Dilworth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.04.006_bib19","doi-asserted-by":"crossref","first-page":"ofz079","DOI":"10.1093\/ofid\/ofz079","article-title":"The impact of concomitant empiric cefepime on patient outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections treated with vancomycin","volume":"6","author":"Zasowski","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40121-020-00292-8","article-title":"Monotherapy with vancomycin or daptomycin versus combination therapy with \u03b2-lactams in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections: A retrospective cohort analysis","volume":"9","author":"Alosaimy","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2026.04.006_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciz746","article-title":"Daptomycin plus \u03b2-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: A retrospective, comparative cohort study","volume":"71","author":"Jorgensen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01554-17","article-title":"Outcomes of vancomycin plus a \u03b2-lactam versus vancomycin only for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"62","author":"Truong","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.04.006_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab261","article-title":"Standardized treatment and assessment pathway improves mortality in adults with methicillin-resistant Staphylococcus aureus bacteremia: STAPH study","volume":"8","author":"Alosaimy","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","article-title":"Overview of antibiotic-induced nephrotoxicity","volume":"8","author":"Campbell","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.cmi.2026.04.006_bib25","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S1473-3099(23)00432-2","article-title":"Understanding vancomycin nephrotoxicity augmented by \u03b2-lactams: A synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and \u03b2-lactam chemistry","volume":"24","author":"Alosaimy","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciy724","article-title":"Incidence of acute kidney injury among critically Ill patients with brief empiric use of antipseudomonal \u03b2-lactams with vancomycin","volume":"68","author":"Schreier","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0885066619828290","article-title":"The risk of acute kidney injury in critically Ill patients receiving concomitant vancomycin with piperacillin-tazobactam or cefepime","volume":"35","author":"Molina","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.cmi.2026.04.006_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: Secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib29","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41591-023-02569-0","article-title":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: A randomized trial","volume":"29","author":"Grillo","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2026.04.006_bib30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ckj\/sfaa059","article-title":"Acute kidney injury following prophylactic flucloxacillin and gentamicin in primary hip and knee arthroplasty","volume":"14","author":"Graham","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.cmi.2026.04.006_bib31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus network adaptive platform trial protocol: New tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.006_bib32","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2023.20583","article-title":"Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: The ACORN randomized clinical trial","volume":"330","author":"Qian","year":"2023","journal-title":"JAMA"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:11:02Z","timestamp":1790035862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1198743X26001904"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.04.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between \u03b2-lactam exposure and clearance of bacteraemia and acute kidney injury in patients with methicillin-resistant Staphylococcus aureus bloodstream infections\u2014a post hoc analysis of the CAMERA2 trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}